Both the study and the analysis were published in the New England Journal on Sept. 2.

FORBES: Magazine Article

Elan and Biogen IDEC are submitting to the FDA based on a one-year analysis of a two-year study.

FORBES: Cheers For Elan, Biogen-Idec